Article Text

Download PDFPDF

Highlights from this issue
Free
  1. The Triumvirate

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

In this edition of “Airwaves” we celebrate some of the unusual news items and colourful characters which have made the news in recent months. We also ponder the meaning (if any) of the current UK Government slogan “levelling up”. In this month’s journal you will find the unusual (bronchial cut-off sign) (see page 422) and the colourful (see the beautiful images derived from bronchoscopic needle based confocal laser endomicroscopy) (see page 370), with a dash of “levelling up”.

Farewell Meatloaf but when will we say farewell air pollution?

In January this year, we bid farewell to the singer “Meatloaf” – famed for the album “Bat out of Hell” which features a very large motorcycle on the cover, belching exhaust gases. The damaging effects of exhaust gases, with particles of aerodynamic diameter less than 2.5 µm (PM2.5), are well described. But what of the even smaller particles in the range 5–560 nm (PNC5–560)? In this issue of Thorax, Fang and colleagues (see page 391) compare measured levels of PNC5–560 with emergency department visits for respiratory problems, by children in Beijing, China. The authors find increased risks of emergency respiratory visits with increases in PNC5–560 on the day the child was seen or the day before. The emissions were largely attributable to petrol and diesel vehicles which increased the risk of emergency respiratory visits by 6.0% and 4.4% respectively. The authors call for traffic emission control in urban areas. With such a high density of traffic in Beijing, Meatloaf might have observed that there is no “Paradise…” to be found “…by the Dashboard Light”.

Captain James T Kirk and advice to air travellers

One of the more bizarre news events of recent months was the blast off of William Shatner (aka Captain James T Kirk of the Star Ship Enterprise) in a real life space shot, in the Blue Origin rocket, owned by Jeff Bezos of (Amazon fame). We are not told whether James T Kirk suffers has respiratory problems but, if he does, he would do well to read: “the BTS Clinical Statement on air travel for passengers with respiratory disease,” published in this month’s Thorax (see page 329). This updated statement provides an exhaustive review of the literature and makes specific recommendations on pre-flight screening tests – in particular which patients should undergo the hypoxic challenge test (HCT). There is specific advice for a wide range of respiratory conditions including asthma, cystic fibrosis, COPD and recent pneumothorax. After touchdown, William Shatner exclaimed “I hope I never recover from this…” before being drenched in champagne. Avoiding champagne (and any other alcoholic drink) during flight is recommended by the consensus statement to avoid venous thromboembolism. With this comprehensive clinical statement clinicians can ensure their respiratory patients do make a full recovery after their flights.

The meaning of levelling up

As we write Airwaves the editors have had sleepless nights, crossing an ocean of tears, trying to understand the meaning of levelling up. This policy was announced with great fanfare this month and many wonder whether there will be losers as well as winners. But, of course, the meaning of this phrase is surely Level 42. The concept of levelling up is to prevent regional geographical differences and indeed they really do exist, not just nationally and internationally as well. In this issue of Thorax(see page 378) Araghi and colleagues describe differences in lung cancer survival by sex, histological type and stage at diagnosis. They find that lung cancer survival was lower in the UK than Canada and Norway, and regardless of lung tumour histology survival was better for females than males. They conclude that while tumour histology and sex differences play a major role in differences in survival, quality of treatment and healthcare system factors also play a big role. So does Level 42 bring only feelings of doubt, gone with the hope the words have erased? We do hope not!

Deep thought

The galaxy is currently full of super computers trying to define the meaning of life, or the value of life in the case of cryptocurrency. However, that answer is known, its 42. Deep thought is also required when considering whether to undertake a lung transplant in an emergency situation, such as an Acute Exacerbation of Interstitial Lung Disease (AE-IILD). In this edition of Thorax (see page 364) Chizinga and colleagues compare the outcomes of 53 patients admitted with AE-IPF. 28 had medical therapy and 25 received a lung transplant. 100% patients with AE-ILD who underwent transplantation, in contrast with only 43% of those treated medically, survived to discharge. During the same period, 67 patients with stable ILD underwent transplantation and survival at 1 year was not different for the AE-ILD or stable ILD patients transplanted (96% vs 92.5%). Now at the risk of being accused of being a paranoid android we think it might be time to re-think the meaning of transplant policies.

Clustering phenotypes

Levelling up is a moral, social and economic programme, although without extra funding it will be seen as levelling out rather than levelling up. Indeed, it would be more useful to consider levelling up as a process of managing clusters of social and economic deprivation. Horsley and colleagues (see page 357) used this clustering approach in the longitudinal assessment of lung clearance index to monitor disease progression in children and adults with cystic fibrosis. The authors assessed the feasibility, repeatability and longitudinal LCI change in children and adults with mild CF as a prospective, 3-year, multicentre, observational study. One hundred and twelve patients completed the study with latent class growth model analysis demonstrating four discrete clusters with baseline LCI as the strongest factor associated with longitudinal change and risk factor for future disease progression. These results support the use of LCI in clinical practice in identifying patients at risk of lung function decline. Annangi and colleagues [thoraxjnl-2020–2 14 644] took a similar approach in COPD and focused on fractional exhaled nitric oxide levels (FENO) and observed that FeNO levels≥25 ppb and peripheral eosinophilia was higher among COPD subjects with asthma compared with COPD without asthma. This clustering and phenotyping of our patients identifies those patients at greatest clinical risk. We can only hope that our politicians are equally as deft at phenotyping and identifying clusters of the UK population at social and economic risk.

Linked Articles

  • Images in Thorax
    Brian Gaffney Liam Chawke Michaela Larkin Gaith Qsous David Healy Michael P Keane Aurélie Fabre David J Murphy Cormac McCarthy
  • Interstitial lung disease
    Mwelwa Chizinga Tiago N Machuca Abbas Shahmohammadi Divya C Patel Ayoub Innabi Bashar Alzghoul Vanessa Scheuble Mauricio Pipkin Borna Mehrad Andres Pelaez Christine Lin Diana Gomez- Manjarres
  • BTS Clinical Statement
    Robina Kate Coker Alison Armstrong Alistair Colin Church Steve Holmes Jonathan Naylor Katharine Pike Peter Saunders Kristofer John Spurling Pamela Vaughn
  • Lung cancer
    Tess Kramer Lizzy Wijmans Martijn de Bruin Ton van Leeuwen Teodora Radonic Peter Bonta Jouke T Annema
  • Cystic fibrosis
    Alex R Horsley John Belcher Katie Bayfield Brooke Bianco Steve Cunningham Catherine Fullwood Andrew Jones Anna Shawcross Jaclyn A Smith Anirban Maitra Francis J Gilchrist
  • Respiratory epidemiology
    Jiakun Fang Xiaoming Song Hongbing Xu Rongshan Wu Jing Song Yunfei Xie Xin Xu Yueping Zeng Tong Wang Yutong Zhu Ningman Yuan Jinzhu Jia Baoping Xu Wei Huang
  • Lung cancer
    Marzieh Araghi Miranda Fidler-Benaoudia Melina Arnold Mark Rutherford Aude Bardot Jacques Ferlay Oliver Bucher Prithwish De Gerda Engholm Anna Gavin Serena Kozie Alana Little Bjørn Møller Nathalie St Jacques Hanna Tervonen Paul Walsh Ryan Woods Dianne L O'Connell David Baldwin Mark Elwood Sabine Siesling Freddie Bray Isabelle Soerjomataram ICBP SURVMARK-2 Local Leads ICBP SURVMARK-2 Academic Reference Group ICBP SURVMARK-2 Local Leads Alana Little Angela Eckstrand Anna Gavin Bin Zhang Bjørn Møller Carol McClure Rebecca Thomas Connie Marano Christine Bertrand Christopher Jackson Claire Austin David Gavin David S Morrison Deirdre Fitzpatrick Donna Turner Dyfed Huws Eshwar Kumar Gail Noonan Geoff Porter Gerda Engholm Gina Lockwood Grace Musto Grlica Bolesnikov Guillaume Ruel Hanna Tervonen Hazem Abd Elkader Heather Stuart-Panko Janet Warlow Jason Poole John Spinelli Lorraine Shack Louise Sandford Marianne Brenn Jerm Maureen MacIntyre Nathalie St-Jacques Oliver Bucher Paul Walsh Prithwish De Raman Agnihotram Richard Trevithick Rory Carle Ryan Woods Sally Vernon Serena Kozie Susan Ryan Sue Evans ICBP SurvMark-2 Academic Reference GroupICBP SurvMark-2 academic reference group Dianne O'Connell Michael Eden Mark Elwood Sabine Siesling ICBP Clinical Committee – LungICBP clinical Committee – lung Anur Guhan Christian Finley Brian McCaughan David Baldwin Erik Jakobsen Ian Williamson Jason Lester Jonathan McAleese Karl Kolbeck Mick Peake Odd Terje Brustugun Paul Dawkins Wendy Anderson